Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4ba0150-8e71-44f1-abed-3e7ed41070ff Date 3/27/2015 Company Name Security Innovation Mailing Address 187 Ballardvale Street Wilmington, MA 01887 USA Company Description Security Innovation is an authority on application security and leading independent provider of risk assessment, risk mitigation and education services to mid-size and Fortune 500 companies. Website http://www.securityinnovation.com Transaction Type Venture Equity Transaction Amount … Continue reading “Security Innovation Garners $4,000,000 New Financing Round”
Category: Boston
What’s Hot in Boston Biotech? Here’s the Agenda
There’s just a few weeks left before our annual biotech extravaganza in Boston. On April 8, we’ll be hosting “What’s Hot in Boston Biotech” at the Broad Institute of MIT and Harvard in Cambridge. We’ve put together a big lineup of executives, scientists, entrepreneurs, and investors across some of the hottest fields of life sciences … Continue reading “What’s Hot in Boston Biotech? Here’s the Agenda”
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill
Over the past year, Gelesis has made the turn from concept to clinic, building up the first data for an anti-obesity pill made out of little particles that swell in the stomach, making a person feel full. With more trials looming, and a second product on the way, the bills are growing—and the Boston startup … Continue reading “Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill”
Amid Gene Editing Worry, A Return To Biotech’s 1st “Asilomar Moment”
Biotechnology leaders—and the rest of us—should “count to 10” as they read the March 19 call in Science to consider limits on using revolutionary new gene-editing techniques for germline gene therapy. The techniques are powerful and simple to use and key scientists, worried about misuse, want us to pause, confer, and set limits. But we … Continue reading “Amid Gene Editing Worry, A Return To Biotech’s 1st “Asilomar Moment””
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date
Flagship Ventures of Cambridge, MA, a major early-stage biotech investor, said today it has closed a $537 million fund, the largest in the firm’s 15-year history. Flagship initially set out to match the $269 million of its previous fund, Flagship senior managing partner and CEO Noubar Afeyan (pictured) said, but biotech momentum changed those plans. … Continue reading “Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date”
Char Software Obtains $34,999,988 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a35d8c13-cbd5-4b04-8f1f-0a28e2c2ac74 Date 3/26/2015 Company Name Char Software Mailing Address 141 Tremont Street 7th Floor Boston, MA 02111 USA Company Description Char Software, Inc. is a Boston based software company focused exclusively on building interactive web and mobile software for its clients and our team possesses deep technical and business experience in the … Continue reading “Char Software Obtains $34,999,988 New Funding Round”
Gelesis Secures $22,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4a3f0eb9-9b4d-426c-adb4-456d58c0271a Date 3/26/2015 Company Name Gelesis Mailing Address 222 Berkeley St. Boston, MA 02116 USA Company Description Gelesis is a Boston-based company developing a breakthrough treatment for obesity and other related co-morbidities. Website http://www.gelesis.com Transaction Type Venture Equity Transaction Amount $22,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds from the financing will be … Continue reading “Gelesis Secures $22,000,000 New Financing”
Neurovance Receives $5,499,459 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9900bb70-942b-4c68-a432-4996cff1bd98 Date 3/26/2015 Company Name Neurovance Mailing Address 43 Thorndike Street Cambridge, MA 02141 USA Company Description Neurovance is a clinical stage neuroscience-focused company. Following development of centanafadine SR (formerly EB-1020 SR) for adult ADHD, Neurovance will develop centanafadine SR for adolescent and pediatric ADHD. Website http://www.neurovance.com Transaction Type Venture Equity Transaction … Continue reading “Neurovance Receives $5,499,459 New Funding”
aPriori Technologies Lands $6,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3936e114-1e83-4159-882c-5f150e9d4ebe Date 3/26/2015 Company Name aPriori Technologies Mailing Address 300 Baker Avenue Concord, MA 01742 USA Company Description aPriori is a venture-backed company developing an innovative platform of cost management software solutions for the discrete manufacturing industry. Website http://www.apriori.com Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “aPriori Technologies Lands $6,000,000 New Funding Round”
Silk Therapeutics Garners $2,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=18e06693-5888-4927-81ce-cbcf716a6fdc Date 3/26/2015 Company Name Silk Therapeutics Mailing Address 196 Boston Ave. Medford, MA 02155 USA Company Description The founders of Silk Therapeutics are world-renowned for pioneering silk science to improve human health. Dr. Greg Altman (CEO) and Dr. Rebecca Horan (COO) have worked together for more than 15 years developing silk-based … Continue reading “Silk Therapeutics Garners $2,000,000 Series A Funding Round”
Boston 2035
What, and who, will be the drivers of Boston’s innovation future? Join us at Boston 2035, the second New England event in our Xponential Cities series. This unique conference will look out 20 years and beyond to explore the long-term prospects of the local high-tech economy—and what can be done to not only preserve, but … Continue reading “Boston 2035”
Hi, I’m in Delaware… For the Fast Internet
Internet speeds are becoming increasingly important to consumer markets, as users of streaming content such as Netflix, Hulu, and HBO multiply. Those people are expecting quality streaming, too, especially with the advent of 4K, or “ultra” high-definition, video. It may be no surprise that broadband Internet speeds vary from state to state, with Virginia, Delaware, … Continue reading “Hi, I’m in Delaware… For the Fast Internet”
Nanigans Nabs $24M to Expand Beyond Facebook, Into Asia
Investors like adtech. The latest example is Boston-based Nanigans, which announced Wednesday it has raised a $24 million Series B round. Cheetah Mobile (NYSE: [[ticker:CMCM]]), a Chinese Internet company, led the round, which included the Wellington Management Company as a new investor. Prior investor Avalon Ventures also participated. Nanigans makes digital advertising automation software for … Continue reading “Nanigans Nabs $24M to Expand Beyond Facebook, Into Asia”
Database Pioneer Stonebraker Wins Turing Award, Including $1 Million
Michael Stonebraker, the MIT computer scientist who created multiple companies based on his foundational work in database management systems, has won the A.M. Turing Award from the Association for Computing Machinery. The award, now funded by Google, includes a $1 million prize, up from $250,000 in recent years. The association selected Stonebraker, who is a researcher … Continue reading “Database Pioneer Stonebraker Wins Turing Award, Including $1 Million”
Semma Therapeutics Obtains $44,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dffdfc24-83c5-427a-8f63-29474e5ee1a3 Date 3/25/2015 Company Name Semma Therapeutics Mailing Address Undisclosed Cambridge, MA 02139 USA Company Description Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of … Continue reading “Semma Therapeutics Obtains $44,000,000 Series A Funding Round”
Nanigans Secures $24,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e6d3841-f777-4342-ad79-8938bf7bee2c Date 3/25/2015 Company Name Nanigans Mailing Address 60 State St. Boston, MA 02109 USA Company Description Founded by veteran entrepreneurs with specialties in performance and social marketing, Nanigans was formed to help advertisers maximize the effectiveness of Facebook advertising. Nanigans is the only real-time bidding platform for the Facebook ads marketplace … Continue reading “Nanigans Secures $24,000,000 Series B Round”
Curoverse Garners $500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0f6c6ab4-18a7-4459-b2ff-89f87f544032 Date 3/25/2015 Company Name Curoverse Mailing Address 51 Melcher St. 1st Floor Boston, MA 02210 USA Company Description Curoverse is entirely built with open source software. At its core, Curoverse uses a free and open source system called Arvados that was first developed for the Harvard Personal Genome Project. Arvados is … Continue reading “Curoverse Garners $500,000 New Financing Round”
eIQnetworks Lands $999,999 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d91b4b0-82f6-4069-a664-c266b512389b Date 3/25/2015 Company Name eIQnetworks Mailing Address 31 Nagog Park Acton, MA 01720 USA Company Description By combining enterprise security management (ESM) with IT governance, risk and compliance (GRC) onto a single platform, eIQnetworks enables Global 2000 enterprises, government agencies and managed security service providers (MSSPs) to drive efficiency and reduce … Continue reading “eIQnetworks Lands $999,999 New Funding”
Semma Secures $44M to Develop Diabetes Stem Cell Therapy
A Harvard professor’s cell therapy for Type 1 diabetes that caused fanfare when he detailed its potential in October has received $44 million of Series A funding. Semma Therapeutics announced today the money will help it bring the potential drug through proof-of-concept in humans. The therapy may be able to generate an unlimited amount of … Continue reading “Semma Secures $44M to Develop Diabetes Stem Cell Therapy”
LogMeIn’s New Rescue Lens App Opens the Eyes of Tech Support
Raise your hand if you’ve ever used FaceTime to help a friend or relative fix a computer, TV, or anything else. Now, have you ever completely ripped up your schedule so you could be there when a repair technician came to your home, only to find when the person showed up—late, of course—the problem was … Continue reading “LogMeIn’s New Rescue Lens App Opens the Eyes of Tech Support”
Localytics Pushes Mobile Marketing with $35M Series D
Localytics may be hitting its stride. In the ever-difficult tightrope walk of increasing revenues while also growing a company, the Boston-based mobile marketing company is doing both. It passed the $10 million mark for revenue run rate in 2014, 2.5 times greater than the prior year, according to CEO Raj Aggarwal. And it has a … Continue reading “Localytics Pushes Mobile Marketing with $35M Series D”
SurgiQuest Garners $9,999,992 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=84c4e7b5-c81c-4c70-8883-13b0220abb21 Date 3/24/2015 Company Name SurgiQuest Mailing Address 333 Quarry Road Milford, CT 06460 USA Company Description SurgiQuest, Inc. was incorporated in 2006 with the goal of removing current technological barriers for minimally invasive surgery. Our focus is the current and emerging trends in bariatric, colo-rectal, general, gynecological and urologic surgery. Website … Continue reading “SurgiQuest Garners $9,999,992 New Financing”
Localytics Secures $35,000,000 Series D Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3146d6c3-2d44-4e83-bde5-6534938608e8 Date 3/24/2015 Company Name Localytics Mailing Address 101 Arch St. 8th Floor Cambridge, MA 02111 USA Company Description Top app publishers and brands use our powerful analytics to build more successful and profitable mobile applications. Website http://www.localytics.com Transaction Type Venture Equity Transaction Amount $35,000,000 Transaction Round Series D Proceeds Purposes The … Continue reading “Localytics Secures $35,000,000 Series D Financing Round”
1366 Technologies Secures $2,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06ca2d05-3621-48b4-a992-717224dc8778 Date 3/24/2015 Company Name 1366 Technologies Mailing Address 6-8 Preston Court Bedford, MA 01730 USA Company Description 1366 Technologies is making silicon solar cells competitive with coal. Our goal is to build on the success of multi-crystalline solar cells and manufacturing capacity to accelerate the transition to solar. Our products and … Continue reading “1366 Technologies Secures $2,000,000 New Funding Round”
Alexion Deal in Hand, Blueprint Readies IPO Pitch
[Corrected, 3/24/15, 1 pm ET, see below] Three weeks ago, Blueprint Medicines inked its first major pharma partnership. Now it wants to woo public investors, too. The Cambridge, MA-based company filed papers on Monday outlining plans for an initial public offering. Should Blueprint complete the IPO, it’ll trade on the Nasdaq exchange under the ticker … Continue reading “Alexion Deal in Hand, Blueprint Readies IPO Pitch”
ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs
ImmunoGen’s claim to fame has been its role in making a “smart bomb” cancer drug that Roche subsidiary Genentech sells for breast cancer. Now it’s hoping for a repeat performance with a new partner, Takeda. Waltham, MA-based ImmunoGen (NASDAQ: [[ticker:IMGN]]) cut a deal with Japan’s Takeda this morning that gives the Japanese firm exclusive rights … Continue reading “ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs”
Pediatric Pitch Day Highlights Kids’ Health Innovation at SXSW
For many entrepreneurs, there is a moment when all the work, planning, hope, and praying comes together to set the business’s growth to warp speed. For Kezia Fitzgerald, who founded CareAline, a Boston maker of a cloth sleeve that securely hides intravenous lines and prevents kids from tugging or pulling them off, that moment could … Continue reading “Pediatric Pitch Day Highlights Kids’ Health Innovation at SXSW”
Fastest Turtle: Healthcare Investing and the U.S. Economy
Given the investment horizons for venture capitalists, we do not necessarily try to time public markets when making new investments—although they obviously influence pre-money valuations, particularly for later rounds. Greater concerns revolve around portfolio companies’ ability to access capital on reasonable terms, and that the general macroeconomic environment is conducive to strong revenue growth. Notwithstanding … Continue reading “Fastest Turtle: Healthcare Investing and the U.S. Economy”
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?
Ben Haugstad is 12 years old and loves Taekwondo. He’s been doing it for six years, and soon he’ll be a black belt. He also has a severe form of hemophilia. His body doesn’t produce the machinery needed to clot blood, and at any moment a bad tumble or a bruise could quickly turn into … Continue reading “Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?”
Innovation Hub: Did a Computer Write This Story?
Forget Malcolm Gladwell and Tom Friedman. The next great journalist could be a computer program. Already, artificial intelligence has been put to work at Forbes, the Associated Press, Reuters, and The Big Ten Network. Coverage of NCAA basketball games, earnings reports, and dips in housing prices are regularly penned by this new breed of “journalist.” … Continue reading “Innovation Hub: Did a Computer Write This Story?”
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline
Drug maker Biogen Idec is one step closer to a breakthrough in the Alzheimer’s disease field. For the first time, an experimental treatment seems to both clear out the telltale clumps of protein called beta amyloid from the brains of Alzheimer’s patients and—more important—slow down those patients’ cognitive decline. At a medical conference in Nice, … Continue reading “Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline”
Lessons From Building a Global Engineering Team
It used to be that if you referenced a “global engineering team” you had contracted with a few freelance developers in a remote location to do a few hours of work per week. There’s a good reason for that: historically, recruiting, retaining, and growing global engineering teams has been a significant challenge. At HubSpot, we … Continue reading “Lessons From Building a Global Engineering Team”
Wallflowr Receives $300,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eb18b3f1-ce15-410e-b2b6-732626943d6f Date 3/20/2015 Company Name Wallflowr Mailing Address One Thompson Square Cambridge, MA 02129 USA Company Description Wallflowr is a company working on developing technologies for a safer home and work environment. Wallflowr has a patent-pending system to detect the proximity of people and advanced control of appliances and devices. Website http://www.wallflowr.com … Continue reading “Wallflowr Receives $300,000 New Round”
NuoDB Lands $9,499,998 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=58499dd2-5dc7-455e-aa64-fae14bca3477 Date 3/20/2015 Company Name NuoDB Mailing Address 215 First Street Cambridge, MA 02142 USA Company Description NuoDB is a NewSQL database. It looks and behaves like a traditional SQL database from the outside but under the covers it’s a revolutionary database solution. It is a new class of database for a … Continue reading “NuoDB Lands $9,499,998 New Round”
MEARS Technologies Secures $14,750,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=505fd0f6-8e75-468f-aa10-20a4522957dd Date 3/20/2015 Company Name MEARS Technologies Mailing Address 189 Wells Ave 3rd Floor Newton, MA 02459 USA Company Description MEARS Technologies is dedicated to delivering a stream of innovative solutions to the global semiconductor industry. We focus on enabling the continued improvement of silicon semiconductor performance at ever finer geometries and … Continue reading “MEARS Technologies Secures $14,750,000 New Round”
ezCater Lands $11,727,053 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b00860a6-172f-4429-b60e-a6a401cf1210 Date 3/20/2015 Company Name ezCater Mailing Address 101 Arch Street Boston, MA 02108 USA Company Description ezCater: The easiest, most reliable way to find and order food from local caterers. Website http://www.ezcater.com Transaction Type Venture Equity Transaction Amount $11,727,053 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory … Continue reading “ezCater Lands $11,727,053 New Financing”
Clinical Ink, CentrosHealth Merge in Paperless Drug Trials Push
Clinical trials software company Clinical Ink is adding new mobile capabilities through a merger with CentrosHealth, in a deal that also comes with a capital infusion into the combined company. Winston-Salem, NC-based Clinical Ink disclosed no financial terms for either the merger or for the new investment, which was led by MPM Capital, the Boston-based … Continue reading “Clinical Ink, CentrosHealth Merge in Paperless Drug Trials Push”
With New Robot, Rodney Brooks and Rethink Are Thinking International
Is there sibling rivalry among robots? There is now. Rethink Robotics has unveiled its new robot, called Sawyer, as a complement to its first robot, Baxter. There is a family resemblance—screen face, long arm, red color—but the new machine is smaller, more precise, and holds the keys to the company’s expansion into global markets and … Continue reading “With New Robot, Rodney Brooks and Rethink Are Thinking International”
Rethink Unveils a New Manufacturing Robot Called Sawyer
There’s a new robot in town. His name is Sawyer. He has one arm and a gripper, a reach of 1 meter, and he weighs 42 pounds. He’s designed to work in manufacturing settings, doing things like testing circuit boards and other precise tasks. He’s apparently more agile and compact than his brother, Baxter, who was … Continue reading “Rethink Unveils a New Manufacturing Robot Called Sawyer”
Milestones of Innovation 4: The Letter That Led to the Atomic Bomb
Crisp statements of a case to a prepared, if skeptical, mind have often changed the history of innovation. Perhaps the most critical example of this in the 20th Century is the memorandum that reached Sir Henry Tizard, chief scientific advisor to Britain’s Air Ministry, 75 years ago today, on the 19th of March, 1940. This … Continue reading “Milestones of Innovation 4: The Letter That Led to the Atomic Bomb”
Kyoto Prize Winner Robert Langer on Innovations to Come
The Kyoto Prize Symposium is now in full flower in San Diego, highlighting Japan’s highest international award for honoring the people who have made significant contributions to the scientific, cultural, and spiritual betterment of mankind. The Kyoto Prize was first awarded in 1985, and for many it has become the most prestigious award available in … Continue reading “Kyoto Prize Winner Robert Langer on Innovations to Come”
GelSight Secures New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a6713bc-a936-4603-834b-2ef6ac03bae0 Date 3/19/2015 Company Name GelSight Mailing Address 179 Bear Hill Rd. Waltham, MA 02451 USA Company Description GelSight, Inc. provides extremely detailed and rapid surface measurements through the novel GelSight sensor technology. Our approach to metrology is flexible: the same core technology can be used to measure any rigid material at … Continue reading “GelSight Secures New Financing”
MHB Labs Receives $1,100,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66d37f51-50c2-48ec-94b8-a417d705e751 Date 3/19/2015 Company Name MHB Labs Mailing Address 200 Boylston Street Chestnut Hill, MA 02467 USA Company Description MHB Labs is a virtual biotech founded by two leading physician-scientists at Men’s Health Boston. Our goal is to leverage clinical insight and industry partnerships to develop new, high-impact products within our field. … Continue reading “MHB Labs Receives $1,100,000 Seed Financing”
Ginkgo Bioworks Secures $9,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c386bfea-8c89-487e-ad5d-c44bed0c2cd0 Date 3/19/2015 Company Name Ginkgo Bioworks Mailing Address 27 Drydock Ave. Boston, MA 02210 USA Company Description At Ginkgo BioWorks we are expanding the role of biology in our world. Nature’s biodiversity holds answers to challenges in health, energy, food, materials, and more. Organism Engineers at Ginkgo learn from Nature to … Continue reading “Ginkgo Bioworks Secures $9,000,000 Series A Funding”
Boston-Based Help Scout, Though Profitable, Takes $6M Series A
Help Scout, a Boston company whose software aids small and medium-sized businesses with e-mail customer support, is taking a $6 million Series A funding round four years after its founding, and after already achieving profitability. The company, profiled by Xconomy in 2011 after it graduated from Techstars Boston, plans to use the funding to invest … Continue reading “Boston-Based Help Scout, Though Profitable, Takes $6M Series A”
Ginkgo Bioworks Grabs $9M Series A For Building Organisms
Ginkgo Bioworks, a synthetic biology company that designs and builds organisms, has received $9 million in Series A funding and is opening an 18,000-square foot “foundry” to make its organism engineering scalable, the company said Wednesday. The company engineers microbes for customers to produce anything from probiotics to cultured ingredients, such as flavors, fragrances, cosmetics, … Continue reading “Ginkgo Bioworks Grabs $9M Series A For Building Organisms”
Meerkat and the Live Streaming Phenomenon at SXSW: A Tech Timestamp
[Updated, 2:59 p.m.] What better place than South by Southwest to encounter technology that distracts you from the world around you? At Capital Factory’s A-List pitch event on March 13, a young woman in the middle of the audience seemed engrossed—not in what the speaker was saying, but in what her phone was recording and the … Continue reading “Meerkat and the Live Streaming Phenomenon at SXSW: A Tech Timestamp”
How to Build a Men’s Health Startup: MHB Labs Gets Romulus Cash
If you watch your share of bad TV, you know how big the market is for erectile dysfunction, low testosterone, and urination problems. In other words, men’s health issues—and the drugs that supposedly treat them. What might surprise you is that a tech investor has just made an interesting deal in the sector. Boston-area venture … Continue reading “How to Build a Men’s Health Startup: MHB Labs Gets Romulus Cash”
New York’s Life Science Disruptors: The Photos
On Monday, I recapped our latest Big Apple biotech event, “New York’s Life Science Disruptors.” Today I’ve come back with the slideshow look at the action. In case you missed it, the event was a candid series of chats with key figures in different spectrums of New York biotech—startups, academics, established companies, and investors. As you … Continue reading “New York’s Life Science Disruptors: The Photos”
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test
It’s always a big moment when a biotech makes the turn from lab experiments to real clinical testing. A startup from Cambridge, MA, is celebrating that turn with a name change, a shift in strategy, and a $43 million round of financing from three pharmaceutical companies. That startup is Nimbus Discovery, formed to use computer … Continue reading “With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test”